相似文献
1
Experiences from the Department of Infectious Disease Epidemiology at Robert Koch Institute.
J Health Monit. 2020 Jun 4;5(Suppl 3):19-20. doi: 10.25646/6506. eCollection 2020 Jun.
2
[150 years since the birth of R. Koch--his life and work].
Epidemiol Mikrobiol Imunol. 1994 Dec;43(4):188-91.
3
4
[Robert Koch's unpublished and unfinished experiments on sheep-pox (author's transl)].
Zentralbl Bakteriol Orig A. 1976 Nov;236(2-3):205-14.
5
[Recommendations of the Robert Koch Institute. Pathogenetic significance of intestinal candida colonization. Report of the "Methods and Quality Assurance in Environmental Medicine" Committee of the Robert Koch Institute].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Jun;47(6):587-600. doi: 10.1007/s00103-004-0860-1.
6
Money and microbes: Robert Koch, tuberculin and the Foundation of the Institute for Infectious Diseases in Berlin in 1891.
Hist Philos Life Sci. 2000;22(1):59-79.
7
[Yearly report for 1952 by the Department of Rabies Control of Robert Koch Institute, Berlin].
Zentralbl Bakteriol Orig. 1954;161(6):342-8.
8
Robert koch: centenary of the discovery of the tubercle bacillus, 1882.
Can Vet J. 1983 Apr;24(4):127-31.
9
[The demonstration of Toxoplasma gondii with animal experiments. II. Experiences and results with the culture methods used in the Robert Koch Institute].
Z Tropenmed Parasitol. 1966 Oct;17(3):328-36.
10
[Robert Koch Institute: expert recommendations on procedures following occupational HIV exposure].
Pharm Unserer Zeit. 1997 Jan;26(1):44-5.
本文引用的文献
1
Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.
BMC Med. 2018 Jul 18;16(1):110. doi: 10.1186/s12916-018-1098-3.
2
Routine screening for colonization by Gram-negative bacteria in neonates at intensive care units for the prediction of sepsis: systematic review and meta-analysis.
J Hosp Infect. 2018 Aug;99(4):367-380. doi: 10.1016/j.jhin.2018.03.017. Epub 2018 Mar 22.
3
PRECEPT: an evidence assessment framework for infectious disease epidemiology, prevention and control.
Euro Surveill. 2017 Oct;22(40). doi: 10.2807/1560-7917.ES.2017.22.40.16-00620.
4
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.
PLoS One. 2017 Jan 6;12(1):e0169368. doi: 10.1371/journal.pone.0169368. eCollection 2017.
5
Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.
PLoS Med. 2016 Oct 18;13(10):e1002150. doi: 10.1371/journal.pmed.1002150. eCollection 2016 Oct.
6
Use of existing systematic reviews for evidence assessments in infectious disease prevention: a comparative case study.
Syst Rev. 2016 Oct 11;5(1):171. doi: 10.1186/s13643-016-0347-9.
7
Neurological sequelae of healthcare-associated sepsis in very-low-birthweight infants: Umbrella review and evidence-based outcome tree.
Euro Surveill. 2016;21(8):30143. doi: 10.2807/1560-7917.ES.2016.21.8.30143.
8
The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis.
Dtsch Arztebl Int. 2014 Sep 1;111(35-36):584-91. doi: 10.3238/arztebl.2014.0584.
9
Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools.
BMC Med Res Methodol. 2014 May 21;14:69. doi: 10.1186/1471-2288-14-69.
Zotero 插件